|
[Related PubMed/MEDLINE]
Total Number of Papers: 170
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: MRSI |
| Long Form |
: MR spectroscopic imaging |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Accelerated MR spectroscopic imaging-a review of current and emerging techniques. |
--- |
| 2 |
2020 |
Dynamic hyperpolarized 13 C MR spectroscopic imaging using SPICE in mouse kidney at 9.4 T. |
HFD, ND, SPICE |
| 3 |
2020 |
High-Resolution Dynamic 31P-MR Spectroscopic Imaging for Mapping Mitochondrial Function. |
--- |
| 4 |
2020 |
Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing. |
MCD, NAFLD, SE-SPI, UIs |
| 5 |
2020 |
Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment. |
cTACE, MR |
| 6 |
2020 |
On the acquisition of the water signal during water suppression: High-speed MR spectroscopic imaging with water referencing and concurrent functional MRI. |
EVI, fMRI, PEPSI |
| 7 |
2020 |
Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized 13 C MRSI. |
aSNR, ORC, TRI, WSVD |
| 8 |
2019 |
3D 31 P MR spectroscopic imaging of the human brain at 3 T with a 31 P receive array: An assessment of 1 H decoupling, T1 relaxation times, 1 H-31 P nuclear Overhauser effects and NAD. |
NOE |
| 9 |
2019 |
Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla. |
ADC, AUC, CART, DWI, OR, PZ |
| 10 |
2019 |
GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults. |
AD, BOLD, FIDLOVS, fMRI, PCP, PET, PiB |
| 11 |
2019 |
Non-Cartesian GRAPPA and coil combination using interleaved calibration data - application to concentric-ring MRSI of the human brain at 7T. |
CRLBs, FID, SNR |
| 12 |
2019 |
Reduction of lipid contamination in MR spectroscopy imaging using signal space projection. |
OVS, PG, ROIs, SpaVar, SSP |
| 13 |
2019 |
Simple and broadly applicable automatic quality control for 3D 1 H MR spectroscopic imaging data of the prostate. |
QC |
| 14 |
2019 |
Simultaneous editing of GABA and GSH with Hadamard-encoded MR spectroscopic imaging. |
CV, GABA, GM, HERMES, PRESS, WM |
| 15 |
2019 |
Simultaneous metabolic and functional imaging of the brain using SPICE. |
fMRI |
| 16 |
2019 |
Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer. |
csPCa, DCE-MRI, DW-MRI, PCa |
| 17 |
2019 |
Water removal in MR spectroscopic imaging with L2 regularization. |
--- |
| 18 |
2019 |
Whole-slice mapping of GABA and GABA+ at 7T via adiabatic MEGA-editing, real-time instability correction, and concentric circle readout. |
GABA, IR, MEGA, MM |
| 19 |
2018 |
1H Spectroscopic Imaging of the Rodent Brain. |
--- |
| 20 |
2018 |
Fully automated atlas-based method for prescribing 3D PRESS MR spectroscopic imaging: Toward robust and reproducible metabolite measurements in human brain. |
COV |
| 21 |
2018 |
High-resolution echo-planar spectroscopic imaging at ultra-high field. |
EPSI, SNR |
| 22 |
2018 |
Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL. |
ADC, AUC, CI, DW, mpMRI, PCa, PSA, ROC, RS, TRUS |
| 23 |
2018 |
Prostate imaging features that indicate benign or malignant pathology on biopsy. |
BPH, DCE, DWI, mpMRI, PET, PSA, PSMA, T2W, TZ |
| 24 |
2018 |
Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized 13C-MRSI. |
ADC, DWI, HP, MR, SUV |
| 25 |
2018 |
Spectral decomposition for resolving partial volume effects in MRSI. |
GM, sDec, WM |
| 26 |
2017 |
Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T. |
DWI, mpMRI, PSA, T2W |
| 27 |
2017 |
Global brain metabolic quantification with whole-head proton MRS at 3T. |
Cho, Cr, NAA, VOI, WH |
| 28 |
2017 |
Influence of macromolecule baseline on 1 H MR spectroscopic imaging reproducibility. |
COVs, MM, TE |
| 29 |
2017 |
Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dual-band suppression for metabolic mapping over the entire brain. |
GOIA, HGDB, MEGA |
| 30 |
2016 |
(1)H MR spectroscopic imaging of the prostate at 7T using spectral-spatial pulses. |
SAR, SPSP |
| 31 |
2016 |
A semiadiabatic spectral-spatial spectroscopic imaging (SASSI) sequence for improved high-field MR spectroscopic imaging. |
RF, SAR, SASSI, SNR, SPSP |
| 32 |
2016 |
Accelerated high-bandwidth MR spectroscopic imaging using compressed sensing. |
CS |
| 33 |
2016 |
Denoising of MR spectroscopic imaging data using statistical selection of principal components. |
CRBs, PCA, SNRs, SSPCs |
| 34 |
2016 |
High-resolution (1) H-MRSI of the brain using SPICE: Data acquisition and image reconstruction. |
--- |
| 35 |
2016 |
Monitoring creatine and phosphocreatine by (13)C MR spectroscopic imaging during and after (13)C4 creatine loading: a feasibility study. |
Cr, PCr, TCr |
| 36 |
2016 |
MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy. |
MRS |
| 37 |
2016 |
Phased-array combination for MR spectroscopic imaging using a water reference. |
SNR, WSVD |
| 38 |
2015 |
(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization. |
NOE |
| 39 |
2015 |
Accelerated 1 H MRSI using randomly undersampled spiral-based k-space trajectories. |
NAA, RMSE, SENSE, TV |
| 40 |
2015 |
Accelerating phase-encoded proton MR spectroscopic imaging by compressed sensing. |
CS |
| 41 |
2015 |
Improved volume selective (1) H MR spectroscopic imaging of the prostate with gradient offset independent adiabaticity pulses at 3 tesla. |
CSDE, GOIA, RF, SNR |
| 42 |
2015 |
Multivendor implementation and comparison of volumetric whole-brain echo-planar MR spectroscopic imaging. |
Cre, NAA, RF |
| 43 |
2015 |
Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liver. |
MR, PDE, PEP, PtdC |
| 44 |
2015 |
Sensitivity encoding for fast (1) H MR spectroscopic imaging water reference acquisition. |
SENSE |
| 45 |
2014 |
Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance. |
CIs, DWI |
| 46 |
2014 |
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis. |
BPF, EDSS, RRMS |
| 47 |
2014 |
Flip-angle mapping of 31P coils by steady-state MR spectroscopic imaging. |
FA, RF |
| 48 |
2014 |
Impacts of MR spectroscopic imaging on glioma patient management. |
MR |
| 49 |
2014 |
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma. |
GB, TMZ |
| 50 |
2014 |
Multiparametric magnetic resonance imaging of the prostate: current concepts. |
DCE, DWI, mpMR, PCa |
| 51 |
2014 |
Sparse spectral deconvolution algorithm for noncartesian MR spectroscopic imaging. |
--- |
| 52 |
2014 |
Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor. |
--- |
| 53 |
2014 |
Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes. |
Cho, CT, CTVs, GBM, MR, MTV, NAA |
| 54 |
2013 |
7T MR spectroscopic imaging in the localization of surgical epilepsy. |
Cr, EEG, ILAE, MR, NAA |
| 55 |
2013 |
Evolution of pattern of injury and quantitative MRI on days 1 and 3 in term newborns with hypoxic-ischemic encephalopathy. |
DTI, FA, HIE, MRI, NAA |
| 56 |
2013 |
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost. |
3DCRT, CE, IMRT, SIB, TPS |
| 57 |
2013 |
MR spectroscopic imaging: principles and recent advances. |
--- |
| 58 |
2013 |
MTF behavior of compressed sensing MR spectroscopic imaging. |
CS, MTF, SNR |
| 59 |
2013 |
Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats. |
--- |
| 60 |
2013 |
Multivoxel H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting. |
CE |
| 61 |
2013 |
Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy. |
BVZ, GPC, OS, PCho, PEth, rGBMs |
| 62 |
2013 |
Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint. |
DCE-MRI, DWI, MRI |
| 63 |
2012 |
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis. |
Cho, CSO, DTI, MS, NAA, NAWM, PP, RR, SP, T2-LL |
| 64 |
2012 |
Investigation of the PSF-choice method for reduced lipid contamination in prostate MR spectroscopic imaging. |
PSF |
| 65 |
2012 |
Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy. |
MR, MRI, RP, TRUS |
| 66 |
2012 |
Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models. |
MR, tCho |
| 67 |
2012 |
Multi-echo acquisition. |
--- |
| 68 |
2012 |
Multimodal imaging utilising integrated MR-PET for human brain tumour assessment. |
DTI, FET, fMRI, Met, MR, MRI |
| 69 |
2012 |
Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer. |
CI, MRI, ROC |
| 70 |
2012 |
Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. |
DCE-MRI, DWI, MR, MRI, ROC, T2WI |
| 71 |
2012 |
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. |
MRI, PCa |
| 72 |
2012 |
SU-E-I-75: A New Method for Prostate Cancer Localization Using Multispectral MRI. |
DCE, DWI |
| 73 |
2012 |
The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging. |
GM, GM, H-MRS, WM |
| 74 |
2012 |
Value of Proton-MR-Spectroscopy in the Diagnosis of Temporal Lobe Epilepsy; Correlation of Metabolite Alterations With Electroencephalography. |
Cho, Cr, EEG, Lac, NAA |
| 75 |
2011 |
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. |
DCE-MRI, DWI, MRI, PCa, RP, RT, T2W |
| 76 |
2011 |
Brain temperature in volunteers subjected to intranasal cooling. |
MMSE, MR |
| 77 |
2011 |
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. |
AA, ADC, AUC, DWI, GBM, MR, NPV, PPV, ROC |
| 78 |
2011 |
MR spectroscopy of normative premature newborns. |
--- |
| 79 |
2010 |
1H-MRSI pattern perturbation in a mouse glioma: the effects of acute hyperglycemia and moderate hypothermia. |
HR-MAS |
| 80 |
2010 |
Clinical and imaging tools in the early diagnosis of prostate cancer, a review. |
CT, DCE-MRI, DWI, MRI, PET, PSA, T2-WI, TRUS |
| 81 |
2010 |
Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. |
SNR |
| 82 |
2010 |
Post-processing correction of the endorectal coil reception effects in MR spectroscopic imaging of the prostate. |
--- |
| 83 |
2010 |
Reproducibility of serial whole-brain MR spectroscopic imaging. |
COV |
| 84 |
2010 |
Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits. |
Cho, Cre, GCS, MR, mTBI, NAA, NPT |
| 85 |
2009 |
1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. |
Gly, mI, TE, WHO |
| 86 |
2009 |
Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment. |
ADP, ICA |
| 87 |
2009 |
Design of cosine modulated very selective suppression pulses for MR spectroscopic imaging at 3T. |
VSS |
| 88 |
2009 |
Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer. |
NMR |
| 89 |
2009 |
Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). |
--- |
| 90 |
2009 |
Potential of (1)H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy. |
PZ, ROC |
| 91 |
2009 |
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. |
C-indices, MRI |
| 92 |
2009 |
Spectral resolution amelioration by deconvolution (SPREAD) in MR spectroscopic imaging. |
SPREAD |
| 93 |
2009 |
Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. |
CE, DWI, PWI, RT |
| 94 |
2008 |
1H MR spectroscopic imaging of phospholipase-mediated membrane lipid release in apoptotic rat glioma in vivo. |
GCV, PLA2 |
| 95 |
2008 |
A clinical comparison of rigid and inflatable endorectal-coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate. |
PFC, SNR |
| 96 |
2008 |
Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32-channel phased-array coil. |
Cho, CRLB, GRAPPA, mI, NAA, PEPSI, SENSE, SNR, tCr |
| 97 |
2008 |
Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T. |
Cho, Cr, NAA, PRESS, TEs, WM |
| 98 |
2008 |
Fast nosological imaging using canonical correlation analysis of brain data obtained by two-dimensional turbo spectroscopic imaging. |
CCA |
| 99 |
2008 |
Fast three-dimensional 1H MR spectroscopic imaging at 7 Tesla using "spectroscopic missing pulse--SSFP". |
RF, spMP-SSFP |
| 100 |
2008 |
Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. |
--- |
|
A Search Service for Abbreviation / Long Form
